Erlotinib and RAD001 (Everolimus) in Patients With Previously Treated Advanced Pancreatic Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
OHSU Knight Cancer Institute
Washington University School of Medicine
Hellenic Cooperative Oncology Group
Novartis
Odense University Hospital
Swiss Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Utah
Novartis